Feed 6986.TWO
69
HeXun Biosciences Co., Ltd.
6986.TWO · TWO
$44.30 +0.45% (+$0.20)
1M -4.55%
Market Cap $2.3B
P/E Ratio 21.19x
Div. Yield 0.44%
ROE 14.98%
Valuation
53 /100
Fair P/E 21.19x
P/FCF 18.20x
EV/EBITDA 15.10x
Growth
100 /100
Growing Rev. growth 80.98%
Book val. growth 33.05%
FCF growth 138.13%
Profitability
100 /100
Strong Gross margin 86.08%
FCF margin 43.60%
Net margin 37.46%
Quality
67 /100
Excellent ROIC 12.44%
Asset turnover 0.34x
ROE 14.98%
Debt
100 /100
Low Debt/Equity 0.05x
Net debt/EBITDA -0.56x
Current ratio 12.75x
Stability
9 /100
Unstable Beta 0.07x
Profitable years 3
Rev. volatility 83.44%
Vprašajte StockBota o 6986.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ji-Hong Huang
Employees
53
Headquarters
Taoyuan City
Prihajajoči dogodki
18 AVG.
Ex-Dividend
Ex-dividend date
17 SEP.
Dividend Payment
Datum plačila
12 MAR.
Earnings
Upcoming earnings report